Ginkgo Bioworks Holdings DNA
NYSE DNA
$6.80 -0.14 (-2.09%)
As of: Sep 9, 2026 · 3:59 PM EDT

Ginkgo Bioworks Holdings (DNA) Interest Expenses (2020 - 2024)

Ginkgo Bioworks Holdings' (DNA) quarterly Interest Expenses came in at $31.4 million in Q4 2024, down 28.72% on a YoY basis from $44.0 million in Q1 2024, and up 439.09% quarter-over-quarter from -$9.3 million in Q3 2024.

Analysis

Ginkgo Bioworks Holdings (DNA) Interest Expenses (2020 - 2024) Analysis & Trends

Ginkgo Bioworks Holdings (DNA) has reported Interest Expenses for 4 consecutive years, with $31.4 million the latest figure, recorded in Q4 2024.

  • For the quarter ending Q4 2024, Interest Expenses fell 28.72% year-over-year to $31.4 million; the trailing twelve-month figure through Dec 2024 stood at $55.8 million (up 267.45% YoY), and the FY2024 full-year result was $94000.0, up 1.08% from the prior year.
  • Interest Expenses grew to $31.4 million in Q4 2024 per DNA's latest filing, from -$9.3 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $44.0 million in Q4 2023 and bottomed at -$15.0 million in Q3 2023.
  • Historically, Interest Expenses has averaged $2.9 million across 4 years, with a median of $570500.0 in 2020.
  • The widest YoY moves for Interest Expenses: up 38.41% in 2024, down 28.72% in 2024.
  • Over 4 years, Interest Expenses stood at $590000.0 in 2020, then retreated by 6.61% to $551000.0 in 2021, then jumped by 7886.75% to $44.0 million in 2023, then dropped by 28.72% to $31.4 million in 2024.
  • According to Business Quant data, Interest Expenses over the past three periods registered $31.4 million, -$9.3 million, and -$10.3 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn 197.00 Mn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn -
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn 30.34 Mn
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn -48.79 Mn
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn -
6 Evotec SE 661.34 Mn 235.46 Mn - -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn -
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn -
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn -3,647.53
10 VivoSim Labs 1.47 Mn 1.47 Mn - 4,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 31.37 Mn
Sep 30, 2024 -9.25 Mn
Jun 30, 2024 -10.31 Mn
Dec 31, 2023 44.01 Mn
Sep 30, 2023 -15.02 Mn
Jun 30, 2023 -14.35 Mn
Dec 31, 2021 551,000.00
Sep 30, 2021 649,000.00
Dec 31, 2020 590,000.00
Sep 30, 2020 592,000.00